Skip to main content

Advertisement

Log in

The Prognostic Significance of Heart Rate for Cardiovascular Disease and Hypertension

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Five decades ago, hypertension was a debated risk factor for the development of cardiovascular disease. After further studies and the introduction of antihypertensive medications, few, if any, have doubted the important role hypertension plays as a cardiovascular risk factor. Today, a growing body of evidence emphasizes the relationship between heart rate and hypertension, and heart rate and cardiovascular disease, which makes the measurement of heart rate an important component of the cardiovascular risk assessment. Current European guidelines for managing arterial hypertension recommend the measurement of heart rate for risk stratification, but there still are no recommendations for treatment. This review discusses the evidence for a relationship between heart rate and cardiovascular mortality and morbidity and hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Goldring W, Chassis H: Antihypertensive therapy: an appraisal. Arch Intern Med 1965, 115:523–525.

    CAS  PubMed  Google Scholar 

  2. Levy RL, White PD, Stroud WD, et al.: Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945, 129:585–588.

    Google Scholar 

  3. Gillmann MW, Kannal WB, Belanger A, et al.: Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993, 125:1148–1154.

    Article  Google Scholar 

  4. Kannel WB, Wilson P, Blair SN: Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985, 109:876–885.

    Article  CAS  PubMed  Google Scholar 

  5. Kannel WB, Kannel C, Paffenbarger RS Jr, et al.: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987, 113:1489–1494.

    Article  CAS  PubMed  Google Scholar 

  6. Dyer A, Persky V, Stamler J, et al.: Heart rate as a prognostic factor for coronary heart disease and mortality findings in three Chicago epidemiological studies. Am J Epidemiol 1980, 112:736–749.

    CAS  PubMed  Google Scholar 

  7. Gillum RF, Makuc DM, Feldman JJ: Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991, 121:172–177.

    Article  CAS  PubMed  Google Scholar 

  8. Benetos A, Rudnichi A, Thomas F, et al.: Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999, 33:44–52.

    CAS  PubMed  Google Scholar 

  9. Kristal-Boneh E, Silber H, Harari G, et al.: The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow up of 3527 male Israeli employees (the CORDIS study). Eur Heart J 2000, 21:116–124.

    Article  CAS  PubMed  Google Scholar 

  10. Rabin S, Mathewson F, Rate F: Relationship of blood pressure in 20–39 year old men to subsequent blood pressure and incidence of hypertension over a 30-year observation period. Circulation 1973, 65:291–300.

    Google Scholar 

  11. Julius S, Jamerson K, Mejia A, et al.: The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990, 264:354–358.

    Article  CAS  PubMed  Google Scholar 

  12. Leitschum M, Cupples LA, Kannel W, et al.: High normal blood pressure progression to hypertension in the Framingham study. Hypertension 1991, 17:22–27.

    Google Scholar 

  13. Post WS, Larson MG, Levy D: Hemodynamic predictors of incident hypertension: the Framingham study. Hypertension 1994, 24:585–590.

    CAS  PubMed  Google Scholar 

  14. Selby JV, Friedman GD, Quesensberry P: Precursor of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol and other serum chemistries. Am J Epidemiol 1990, 131:1017–1027.

    CAS  PubMed  Google Scholar 

  15. Stem MP, Morales PA, Hafner SM, et al.: Hyperdynamic circulation and insulin resistance syndrome (‘syndrome X’). Hypertension 1992, 20:802–808.

    Google Scholar 

  16. Kim JR, Kiefe CI, Liu K, et al.: Heart rate and subsequent blood pressure in young adults. The CARDIA study. Hypertension 1999, 33:640–646.

    CAS  PubMed  Google Scholar 

  17. Widimsky J, Fejfarova MH, Fejfar Z: Changes in cardiac output in hypertensive disease. Cardiologia 1957, 31:381–389.

    Article  CAS  PubMed  Google Scholar 

  18. Julius S, Pascual AV, London R: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971, 44:413–418.

    CAS  PubMed  Google Scholar 

  19. Julius S, Pascual AV, Sannerstedt R, et al.: Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 1971, 43:382–390.

    CAS  PubMed  Google Scholar 

  20. Julius S: Borderline hypertension: epidemiologic and clinical manifestation. In Hypertension: Pathophysiology and Treatment. Edited by Genest J, Loiw E, Kuchel O. New York: McGraw-Hill; 1977:630–640.

    Google Scholar 

  21. Messerli FH, Frolich ED, Suarez DH, et al.: Borderline hypertension: relationship between age hemodynamics and circulating catecholamines. Circulation 1981, 64:760–764.

    CAS  PubMed  Google Scholar 

  22. Julius S, Krause L, Schork N, et al.: Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991, 9:77–84.

    CAS  PubMed  Google Scholar 

  23. Kjeldsen SE, Schork NJ, Leren P, et al.: Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension. Am Heart J 1989, 118:775–781.

    Article  CAS  PubMed  Google Scholar 

  24. Stamler J, Berkson DM, Dyer A, et al.: Relationship of multiple variables to blood pressure—findings from four Chicago epidemiologic studies. In Epidemiology and Control of Hypertension. Edited by Oglesby P. New York, London: Stratton Intercontinental Medical Book Corporation; 1975:307–352.

    Google Scholar 

  25. Casiglia E, Zamboni S, Mormino P, et al.: Hypertension, glycaemia and blood lipids in a general population. Eur Heart J 1989, 10:815–820.

    Google Scholar 

  26. Staessen JA, Fagard R, Amery A: Life style as a determinant of blood pressure in the general population. Am J Hypertens 1994, 7:685–694.

    CAS  PubMed  Google Scholar 

  27. Paffenbarger RS, Thorne MC, Wing AL: Chronic disease in former college students. VIII. Characteristics in youth predisposing to hypertension in later years. Am J Epidemiol 1968, 88:25–32.

    PubMed  Google Scholar 

  28. Garrison RJ, Kannel WB, Stokes J, Castelli WP: Incidence and precursors of hypertension in young adult. The Framingham Offspring Study. Prev Med 1987, 16:235–251.

    Article  CAS  PubMed  Google Scholar 

  29. Palatini P, Dorigatti F, Zaetta V, et al.: Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens 2006, 24:1873–1880.

    Article  CAS  PubMed  Google Scholar 

  30. Inoue T, Iseki K, Iskei C, et al.: Higher heart rate predicts the risk developing hypertension in normotensive screened cohort. Circ J 2007, 71:1755–1760.

    Article  PubMed  Google Scholar 

  31. • Flaa A, Eide I, Kjeldsen SE, et al.: Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension 2008, 52:336–341. This article concludes that the sympathetic nervous system probably plays a key role in the pathogenesis of essential HT and that elevated HR may represent sympathetic overactivation.

    Article  CAS  PubMed  Google Scholar 

  32. Strand AH, Gudmundsdottir H, Os I, et al.: Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years. J Hypertens 2006, 24:905–913.

    Article  CAS  PubMed  Google Scholar 

  33. Palatini P: Heart rate as an independent risk factor for cardiovascular disease. Drugs 2007, 67(Suppl 2):3–13.

    Article  PubMed  Google Scholar 

  34. • Mancia G, De Backer G, Dominiczak A, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105–1187. This article represents the first international consensus to consider elevated HR a risk factor for development of CVD and HT.

    Article  CAS  PubMed  Google Scholar 

  35. Palatini P, Benetos A, Julius S: Impact of increased heart rate on clinical outcomes in hypertension. Implications for antihypertensive drug therapy. Drugs 2006, 66:133–144.

    Article  CAS  PubMed  Google Scholar 

  36. Palatini P, Julius S: Heart rate and the cardiovascular risk. J Hypertens 1997, 15:3–17.

    Article  CAS  PubMed  Google Scholar 

  37. Jamerson KA, Julius S, Gudbrandsson T, et al.: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993, 21:618–623.

    CAS  PubMed  Google Scholar 

  38. Jamerson KA, Smith SD, Amerena JV: Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension 1994, 23:1006–1011.

    CAS  PubMed  Google Scholar 

  39. Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest 1980, 65:717–721.

    Article  CAS  PubMed  Google Scholar 

  40. DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev 1997, 77:75–197.

    CAS  PubMed  Google Scholar 

  41. DiBona GF: Neural control of the kidney: past, present and future. Hypertension 2003, 41:621–624.

    Article  CAS  PubMed  Google Scholar 

  42. Folkow B: Physiological aspects of essential hypertension in humans. Physiol Rev 1982, 62:347–504.

    CAS  PubMed  Google Scholar 

  43. Folkow B: Early structural changes in hypertension: pathophysiology and clinical consequences. J Cardiovasc Pharmacol 1993, 22(Suppl 1):1–6.

    Google Scholar 

  44. Mulvany MJ, Aalekjær C: Structure and function of small arteries. Physiol Rev 1993, 73:725–764.

    Google Scholar 

  45. Mulvany MJ: Are vascular abnormalities a primary cause or secondary consequence of hypertension? Hypertension 1991, 18(Suppl 1):52–57.

    Google Scholar 

  46. Julius S: The blood pressure seeking properties of the central nervous system. J Hypertens 1998, 6:177–185.

    Article  Google Scholar 

Download references

Disclosure

Dr. Kjeldsen has received limited lecture honoraria from AstraZeneca, Boehringer-Ingelheim, LEO Pharma, Menarini Group, Sanofi, Servier, Sankyo, and Takeda. No other potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Trygve B. Tjugen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tjugen, T.B., Flaa, A. & Kjeldsen, S.E. The Prognostic Significance of Heart Rate for Cardiovascular Disease and Hypertension. Curr Hypertens Rep 12, 162–169 (2010). https://doi.org/10.1007/s11906-010-0104-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-010-0104-8

Keywords

Navigation